Novartis AG (NOVN.SW) - Income Statement

Home
NOVN.SW
Financials

98.41 (CHF) • At close September 16, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998
Revenue Numbers are in millions	46,660	51,828	52,877	49,898	48,677	53,166	50,135	49,436	50,387	53,634	58,831	57,561	59,375	51,561	45,103	42,584	38,947	36,749	32,526	28,247	24,864	23,151	19,335	21,832	20,418	23,039.244
Cost of Revenue Numbers are in millions	12,472	15,486	15,867	15,121	14,425	18,407	17,175	17,520	17,404	17,345	19,608	18,756	18,983	14,488	12,179	11,439	11,032	10,299	8,868	6,625	5,894	5,441	4,759	6,245	5,229	7,305.233
Gross Profit Numbers are in millions	34,188	36,342	37,010	34,777	34,252	34,759	32,960	31,916	32,983	36,289	39,223	38,805	40,392	37,073	32,924	31,145	27,915	26,450	23,658	21,622	18,970	17,710	14,576	15,587	15,189	15,734.012
Gross Profit Ratio Numbers are in millions	0.733	0.701	0.7	0.697	0.704	0.654	0.657	0.646	0.655	0.677	0.667	0.674	0.68	0.719	0.73	0.731	0.717	0.72	0.727	0.765	0.763	0.765	0.754	0.714	0.744	0.683
Reseach & Development Expenses Numbers are in millions	11,371	9,996	9,540	8,980	9,402	9,074	8,972	9,039	8,935	9,086	9,852	9,332	9,583	9,070	7,469	7,217	6,430	5,349	4,846	4,207	3,756	3,099	2,528	2,840	2,670	2,707.122
General & Administrative Expenses Numbers are in millions	0	0	0	0	0	0	2,136	2,194	2,475	2,616	3,060	2,937	2,970	2,481	2,281	2,245	2,133	1,957	1,742	1,540	1,381	1,146	491	0	0	1,292.878
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	12,861	11,998	11,772	12,377	14,549	14,353	15,079	13,316	12,050	11,852	11,126	10,454	9,802	8,873	9,325	6,737	7,165	0	0	6,388.081
SG&A Numbers are in millions	12,517	14,253	14,886	14,197	14,369	16,471	14,997	14,192	14,247	14,993	17,609	17,290	18,049	15,797	14,331	14,097	13,259	12,411	11,544	10,413	9,325	8,977	7,656	7,941	6,952	7,680.959
Other Expenses Numbers are in millions	0	2,896	895	1,448	1,395	1,045	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Expenses Numbers are in millions	24,419	27,145	25,321	24,625	25,166	26,590	24,331	23,648	24,006	25,200	28,313	27,294	29,394	25,547	22,942	22,181	21,134	18,501	16,753	15,083	13,081	12,076	10,184	10,781	10,571	10,388.081
Operating Income Numbers are in millions	9,769	9,197	26,948	10,152	9,086	8,169	8,629	8,268	8,977	11,089	10,910	11,511	10,998	11,526	9,982	8,964	6,781	7,949	6,905	6,539	5,889	5,634	4,392	4,806	4,618	5,345.93
Operating Income Ratio Numbers are in millions	0.209	0.177	0.51	0.203	0.187	0.154	0.172	0.167	0.178	0.207	0.185	0.2	0.185	0.224	0.221	0.211	0.174	0.216	0.212	0.231	0.237	0.243	0.227	0.22	0.226	0.232
Total Other Income Expenses Net Numbers are in millions	-227	-826	-811	-274	-146	6,372	1,108	233	266	1,918	600	552	502	804	358	567	576	299	295	281	130	420	564	395	369	446.221
Income Before Tax Numbers are in millions	9,123	8,371	26,137	9,878	8,940	13,835	8,999	7,817	8,134	12,272	10,735	11,243	10,773	11,702	9,922	9,499	7,487	8,301	7,265	6,908	6,068	6,289	5,108	5,505	5,341	5,792.151
Income Before Tax Ratio Numbers are in millions	0.196	0.162	0.494	0.198	0.184	0.26	0.179	0.158	0.161	0.229	0.182	0.195	0.181	0.227	0.22	0.223	0.192	0.226	0.223	0.245	0.244	0.272	0.264	0.252	0.262	0.251
Income Tax Expense Numbers are in millions	551	1,416	2,119	1,807	1,793	1,221	1,296	1,119	1,106	1,545	1,443	1,625	1,528	1,733	1,468	1,336	947	1,282	1,124	1,126	1,008	1,065	869	1,110	1,153	1,366.279
Net Income Numbers are in millions	14,850	6,955	24,021	8,072	7,147	12,611	7,703	6,712	17,783	10,210	9,175	9,270	8,940	9,794	8,400	8,195	11,946	7,175	6,130	5,365	4,743	4,725	3,836	4,467	4,181	4,367.733
Net Income Ratio Numbers are in millions	0.318	0.134	0.454	0.162	0.147	0.237	0.154	0.136	0.353	0.19	0.156	0.161	0.151	0.19	0.186	0.192	0.307	0.195	0.188	0.19	0.191	0.204	0.198	0.205	0.205	0.19
EPS Numbers are in millions	7.15	3.19	10.71	3.55	3.12	5.44	3.28	2.82	7.4	4.21	3.76	3.93	3.75	4.28	3.7	3.62	5.15	3.06	2.63	2.28	1.99	1.88	1.49	1.7	0.62	0.33
EPS Diluted Numbers are in millions	7.1	3.17	10.63	3.52	3.08	5.38	3.25	2.8	7.29	4.13	3.7	3.89	3.7	4.26	3.69	3.59	5.13	3.04	2.62	2.27	1.97	1.84	1.49	1.7	0.62	0.33
EBITDA Numbers are in millions	18,469	16,389	33,061	17,211	15,616	21,750	9,776	15,037	14,364	17,727	16,408	16,921	17,338	15,813	12,709	12,333	10,418	10,519	9,174	8,369	7,264	5,904	4,413	5,389	5,198	6,354.651
EBITDA Ratio Numbers are in millions	0.396	0.316	0.625	0.345	0.321	0.409	0.195	0.304	0.285	0.331	0.279	0.294	0.292	0.307	0.282	0.29	0.267	0.286	0.282	0.296	0.292	0.255	0.228	0.247	0.255	0.276

Novartis AG

SIX:NOVN.SW Add to watchlist

SIX:NOVN.SW